Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -40.21M |
| June 30, 2022 | -30.97M |
| June 30, 2021 | -19.90M |
| Date | Value |
|---|---|
| September 30, 2020 | -19.38M |
| September 30, 2019 | -14.62M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-40.21M
Minimum
Jun 2023
-14.62M
Maximum
Sep 2019
-25.02M
Average
-19.90M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| RayzeBio inc (DELISTED) | -45.26M |
| Zai Lab Ltd | -14.92M |
| WuXi Biologics (Cayman) Inc | -- |
| Axonics Inc | -9.236M |
| I-MAB | -- |